We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TTMI:NASDAQTTM Technologies, Inc. Analysis

Data as of 2026-09-01 - not real-time

$114.92

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind TTM Technologies, Inc. is neutral at $114.92, with no clear ordering between short and long averages. Over a rolling month the price has lost 21.7%. Momentum indicators put RSI at 41.4 (neutral) with MACD reading bullish. Price has been bracketed by support at $103.66 and resistance at $149.94.
Multiples put this in fair territory: 51.8 times earnings against the sector's 35.3. Sell-side targets cluster 86.4% above the current quote. Revenue is growing at 37.4% on a 7.0% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 93.8%, a beta of 3.36 and a maximum drawdown of 54.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.

Top Market Events

TTM Technologies Inc TTMI reports a 37% year-over-year revenue surge to $1 billion, driven by robust data center and...PCB manufacturing company TTM Technologies NASDAQ:TTMI reported in Q2 CY2026, with sales up 37.Voya Investment Management, an investment management company, released its second-quarter 2026 investor letter for its...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading below the 200-day average of 119.35
  • MACD momentum is positive
  • 30-day price change of -21.7%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 51.8 versus sector average of 35.3
  • Trading below the 200-day average of 119.35
  • Analyst targets imply +86.4% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 51.8 versus sector average of 35.3
  • Analyst targets imply +86.4% versus the current price
  • Revenue growth of +37.4%

Key Metrics & Analysis

Financial Health

Revenue Growth37.40%
Profit Margin7.01%
P/E Ratio51.8
ROE13.26%
ROA5.25%
Debt/Equity57.03
P/B Ratio6.5
Op. Cash Flow$322.9M
Free Cash Flow$-19442376
Industry P/E35.3

Technical Analysis

TrendNeutral
RSI41.4
Support$103.66
Resistance$149.94
MA 20$125.45
MA 50$139.66
MA 200$119.35
MACDBullish
VolumeDecreasing
Fear & Greed Index93.7

Valuation

Fair Value$68.83
Target Price$214.25
Upside/Downside86.44%
GradeFair
TypeGrowth

Risk Assessment

Beta3.36
Volatility93.84%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.